Answers are grounded in this paper and cite their sources.
Demonstrates improved prediction of cancer cell line sensitivity in pharmacogenomic contexts, indicating potential for precision oncology.
The identification of effective anticancer agents from plant‐derived compounds remains a major challenge due to the complex interplay between chemical structure and tumor‐specific molecular profiles. In this study, we present PhytoMedica, a machine learning‐based framework for predicting the sensitivity of cancer cell lines to plant‐derived compounds using integrated pharmacogenomic data. A curated dataset comprising approximately ∼1,673 drug–cell line interactions was constructed from the genomics of drug sensitivity in cancer (GDSC) resource, incorporating molecular descriptors, mutation profiles, and gene expression features. Drug response values (IC 50 ) were transformed into binary activity classes using percentile‐based thresholding to enhance class separability. An ensemble learning strategy combining random forest, XGBoost, LightGBM, and logistic regression was implemented within a stacking framework to capture complex nonlinear relationships. Class imbalance was addressed using cost‐sensitive learning and stratified sampling, resulting in improved predictive performance, particularly for the minority class (F1‐score ∼0.76). The final model achieved an AUC of approximately 0.91 on the independent test set, while cross‐validation yielded an average AUC of approximately 0.71, reflecting robust generalization across heterogeneous pharmacogenomic data. PhytoMedica offers reliable, interpretable and scalable platform for using multi‐omic and chemical data to facilitate data‐driven discovery of therapeutic agents derived from plants for precision oncology.
No takes yet. Share an insight, caveat, or question.
Zainab et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: